Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01501 INT MEDICAL
RT Nominal up28.050 +0.200 (+0.718%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others789,08324.526%633,671458,153199,253114,573
Land & other Lease Assets109,201-5.815%115,943106,820100,91744,621
Intangible Assets130,37486.462%69,92027,8777,6035,899
Interests in Asso. & JCEs0--0000
Other Non-current Assets276,67934.402%205,859170,25966,7959,825

1,305,33727.301%1,025,393763,109374,568174,918
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories128,770-16.533%154,27792,49455,20643,421
Trade Receivables122,91972.201%71,38178,67323,65514,701
Cash & Bank Balances423,668-18.253%518,266640,550870,1321,036,783
Other Current Assets48,932-15.659%58,01746,71999,12328,757
Assets Held for Sale0--0000

724,289-9.683%801,941858,4361,048,1161,123,662
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables32,854-9.682%36,37626,81515,85716,430
S-T Debt & Leases79,123140.612%32,884192320206
Other Current Liabilities204,85220.215%170,405126,21472,13542,567
Liab asso w/ Assets Held for Sale0--0000

316,82932.197%239,665153,22188,31259,203
Net Current Assets407,460-27.534%562,276705,215959,8041,064,459
Total Assets Less Current Liabilities1,712,7977.881%1,587,6691,468,3241,334,3721,239,377
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases15,656-1.806%15,94413,2121,4131,620
Other Non-current Liabilities18,7636.481%17,62117,1925,3113,470

34,4192.544%33,56530,4046,7245,090
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital171,0001.786%168,000166,000166,000166,000
  Reserves1,478,2419.987%1,344,0151,229,4721,139,6501,050,381
  Others0--0000
Shareholders' Funds1,649,2419.076%1,512,0151,395,4721,305,6501,216,381
Non-controlling Interests29,137-30.773%42,08942,44821,99817,906
Others0--0000

1,678,3787.997%1,554,1041,437,9201,327,6481,234,287
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments152,777-42.621%266,260598,475539,973418,768
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 30/07/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB 156,457,000
%Change18.786%
EPS / (LPS)RMB 0.920
NBV Per Share (¥)RMB 9.645
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.